MGH INSTITUTE FOR TECHNOLOGY ASSESSMENT - Key Persons
Asmae Toumi holds a Bachelor of Science in the Life Sciences from McGill University, where she also pursued clinical and basic science research. She is a past recipient of an American Physiological Society Undergraduate Research Fellowship. At the ITA, she worked on health outcomes research under Dr. Jag Chhatwal and Dr. Carrie Lubitz. She is passionate about data science, healthcare optimization, and sports analytics.
- Associate Clinical Director of Liver Transplantation
Dr. Bethea completed Gastroenterology and Hepatology fellowship followed by an Advanced Transplant Hepatology fellowship at Massachusetts General Hospital. She remains active in numerous societies and organizations, including the MGH Institute for Technology Assessment where she continues to apply simulation modeling and decision analytic methods to answer clinical questions and improve resource optimization in the areas of viral hepatitis, non-alcoholic fatty liver disease, and organ transplantation.
- Director, MGH Fatty Liver Clinic, Gastroenterology Unit at Massachusetts General Hospital
Kathleen E Corey, MD, MPH, MMSc is an Assistant Professor of Medicine at Harvard Medical School. Dr. Corey's clinical interests include all areas of hepatology. Dr. Corey's research focuses on non-alcoholic fatty liver disease and the development of non-invasive biomarkers for the diagnosis and monitoring of NAFLD. Dr. Corey has lectured regionally and nationally on NAFLD
Ozden Onur Dalgic was a postdoctoral fellow at MGH-ITA. His research focuses on data analytics, agent-based simulation, stochastic programming, Markov models and decision processes, infectious disease modeling, and natural history models. Ozden is currently working with Jagpreet Chhatwal, PhD. He is also a Research Collaborator at Neurology Department, Mayo Clinic, Rochester, MN.
- Director, NAFLD Research Center
- Professor of Medicine
Dr. Loomba is Professor of Medicine (with tenure) in the Division of Gastroenterology, and Adjunct Professor in the Division of Epidemiology at University of California, San Diego. He is a leading expert in translational research and innovative clinical trial design in NAFLD and NASH. Dr. Loomba is the founding director of the UCSD NAFLD Translational Research Unit where his team is conducting cutting edge research in all aspects of NAFLD including non-invasive biomarkers, genetics, epidemiology, clinical trial design, imaging end-points, and integrated OMICs using microbiome, metabolome and lipidome. He follows one of the largest cohorts of well-characterized patients with NAFLD and applies evidence-based medicine to answer clinically relevant questions to improve management of patients with chronic liver disease. Dr. Loomba is an elected member of the board of directors of the American Liver Foundation. He serves as the co-chair of the Research Award Panel for the American Liver Foundation. In addition, he serves on various committees of the American Association for the Study of Liver Diseases (AASLD). He serves on the editorial board of several leading journals, and is the Associate Editor for Alimentary Pharmacology and Therapeutics, a leading journal in the field of Gastroenterology.
Dr. Samur was a postdoc fellow at Harvard Medical School and Massachusetts General Hospital (MGH), Institute for Technology Assessment. During her research, she mainly worked in liver diseases including hepatitis C virus, nonalcoholic fatty liver, and liver transplant. She has authored/co-authored over 30 publications including papers, proceedings, and abstracts. Her research has been featured in the media more than 20 times, including in press releases and interviews. In June 2018, The Massachusetts State House of Representatives honored Dr. Samur for her outstanding contribution to the study of health care and the future of medicine in the US. Dr. Samur holds a PhD degree in Industrial Engineering from Marmara University, Turkey.
Dr. Chen received her PhD in Interdisciplinary Statistics and Operations Research from the University of North Carolina at Chapel Hill, and an MS in Operations Research from Columbia University, New York. She obtained her BS in Electrical Engineering from the Southeastern University in Nanjing, China. With an innate interest in math, Dr. Chen was wheeled back to the major of Operations Research after stumbling across a class in Stochastic Modeling at Columbia University. Her graduate research was centered around applying statistical analysis, Queueing Theory, and simulation techniques to streamline patient flows in emergency departments. She has always enjoyed working in the healthcare management industry, where she cooperates with professionals with various technical backgrounds to combine group wisdom into advancing innovative healthcare operations and cost-effective healthcare policies. At the ITA, she worked with Dr. Jagpreet Chhatwal on the development of non-alcoholic fatty liver disease (NAFLD) progression model.